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Chapter 1: Introduction 
 Eighty – eight years ago (in 1928) penicillin, “the miracle drug”, was discovered.  It was 
until 1942 that penicillin was used to successfully treat a civilian patient. [1] Since then modern 
medicine has given us vaccines for the flu, pneumonia, and meningitis; allowed us to transplant 
hearts, kidneys, and lungs; and enabled us to sequence the human genome. [2] Even with all of 
these incredible advances in technology, currently most delivery systems are still non-selective, 
meaning the drug harms healthy cells as well as disease cells. The damage to healthy cells is 
what leads to the undesirable side effects caused by many medicines today. By designing a 
selective delivery system such as peptoid nanospheres, drug side effects could be drastically 
reduced and possibly eliminated.  
Chapter 2: Background 
Section 2.1: Peptoids 
 Peptoids are poly-N-substituted glycines as shown in Figure 1. [3] By using peptoids 
instead of peptides, protease degradation can be avoided. [4] Protease degradation is 
particularly concerning for this application because the goal is to deliver medicine to diseased 
cells. If protease degradation were to occur, the medicine would be released before reaching 
the desired destination rendering the targeting mechanism useless. 
 
Figure 1. Peptoids vs. Peptides [4] 
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Another benefit of peptoids is that peptoid alpha helixes have a three pitch turn 
meaning every third side chain stacks precisely on top of the previous one. [5] This allows the 
charges to align on one side which is believed to aid in nanosphere formation. 
Section 2.2: Peptoid Selection 
Having the side chain bonded to the nitrogen makes the backbone achiral but chirality is 
needed for peptoid formation. To induce chirality, large chiral side chains are used. Peptoids 
were chosen such that two aromatic rings are followed by a charged side chain. Two positively 
charged side chains followed by two negatively charged side chains were used because previous 
research showed this sequence was most likely to induce nanosphere formation. An example 
structure is shown in Figure Figure 2: Peptoid Sequence2. 
 
Figure 2: Peptoid Sequence 
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Section 2.3: Mechanism Theory 
 The peptoids will be used to form nanospheres then the nanospheres will be attached 
to peptoids known to bind to specific proteins found at much higher concentrations or 
exclusively on diseased cells. The peptoid nanospheres will form tertiary structures, as shown in 
Figure 3, which will allow them to form spheres. The aromatic rings will stack on two sides and 
the charges align on the third.  
 
Figure 3: Peptoid Sphere Formation [5] 
The peptoid nanospheres will then be attached to affinity peptoids which will target the 
diseased cells as shown in Figure 4. Upon binding, the medicine will be released at the disease 
site. The medicine could be released in the cells due to endocytosis. If endocytosis does not 
occur, the medicine could be released using an external source such as heat or ultrasound. 
 
Figure 4: Targeting Mechanism 
6 
 
Chapter 3: Methods 
 Before conducting experiments, the peptoids were synthesized then purified to greater 
than 98% using high performance liquid chromatography. Matrix assisted laser desorption 
ionization was used to confirm the peptoids synthesized properly by verifying the molecular 
weight. Circular dichroism was used to determine the helicity before proceeding with 
nanosphere testing. Scanning electron microscopy showed if peptoids formed on a solid 
substrate. Finally, dynamic light scattering in conjunction with transmission electron microscopy 
was used to determine if spheres formed in solution. 
Section 3.1: Peptoid Synthesis 
Peptoid synthesis is a submonomer process that begins with an amine group attached 
to a rink amide resin. [6] The resin is swelled using 40 mL of dimethylformamide (DMF) per 1 
mmol of resin determined by weight, then drained. The Fmoc group is then deprotected using 
20% piperdine in DMF at 40 mL/mmol concentration. This step is repeated to ensure the Fmoc 
group is completely deprotected. The resin is then rinsed using DMF at 40 mL/mmol five times. 
To begin the submonomer process, 1.2 molar bromoacetic acid at a concentration of 17 
mL/mmol resin is used to acylate the amine. This is done in the presence of 
diisopropylcarbodiimide (DIC) at a concentration of 3.2 mL/mmol resin. The resin is rinsed three 
times with 40 mL/mmol DMF before 17 mL/mmol of a 1 molar solution of the desired side chain, 
typically in DMF, is added to the solution. The bromine is displaced by the desired sidechain 
using an SN2 mechanism. This process is repeated until the desired peptoid is synthesized.  
Before the peptoid can be used it must be cleaved from the resin. To begin this process 
the peptoid on resin is dissolved in 10 mL of a 95% trifluoroacetic acid (TFA), 2.5% 
triisopropylsilane, and 2.5% water solution then swirled for ten minutes. Immediately the 
peptoid solution is filtered to remove the resin beads then rotary evaporated. Once the sample 
7 
 
has reached an oily state in the rotary evaporator, it is dissolved in just enough 50/50 
acetonitrile and water mixture to have a concentration of 3 mg/mL based off the original sample 
weight. 
Section 3.2: High Performance Liquid Chromatography 
 High performance liquid chromatography (HPLC) was used to purify the sample then 
analytical HPLC was analyzed to determine the purity of the sample. Before using the HPLC, all 
solvents were sparged with hydrogen for 30 min to ensure no air entered the column. Once 
sparging was complete, solvent A (94.5% water, 5% acetonitrile, and 0.5% (TFA) was run for 10 
minutes followed by 10 minutes of solvent B (94.5% acetonitrile, 5% water, and 0.5% TFA) then 
the column was equilibrated with starting conditions for 10 minutes. Three milliliters of 3 
mg/mL peptoid dissolved in 50/50 acetonitrile and water was injected into the HPLC then a 1% 
gradient per minute from 30 to 95% acetonitrile was run. Ultraviolet light was used to 
determine when peptoid was leaving the column and these samples were collected. The 
collected samples were analyzed using analytical HPLC and matrix assisted laser desorption 
ionization. 
Section 3.3: Matrix Assisted Laser Desorption Ionization 
 Matrix assisted laser desorption ionization (MALDI) was used to confirm the correct 
peptoid was synthesized. To perform MALDI, 1 μl of peptoid sample was mixed with 1 μl of DHB 
matrix then dried on a metal plate. Standards were ran before testing the samples. The 
molecular weight estimated by MALDI was then compared to the predicted molecular weight to 
determine if the peptoid synthesized properly. 
Section 3.4: Circular Dichroism 
 Circular dichroism determines the relative helicity of the peptoids by comparing the 
difference in light absorption between left and right circularly polarized light. The circular 
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dichroism value was calculated by subtracting the right circularly polarized light from the left 
circularly polarized light. [7] This experimental value was then compared to known values to 
determine the peptoid structure. 
Section 3.5: Scanning Electron Microscopy 
Scanning electron microscopy (SEM) uses an electron beam to form an image of a 
surface. [8] The anode directs the electron beam down the column towards the specimen as 
shown in Figure 5. [9] The beam then proceeds through a series of magnetic lenses. The 
condenser lens controls the spot size and an objective lens controls where the beam comes into 
focus. The stagnator makes the electron beam round before it contacts the sample. [10] When 
the electrons hit the sample, electrons and x-rays are emitted. [9] Detectors collect data from 
each of these emissions and convert it to a signal which is used to construct an image of the 
surface. [8] 
 
Figure 5: Scanning Electron Microscope [8] 
For SEM, samples must be conductive and completely dry. SEM is performed under a 
vacuum to prevent air molecules from interfering with the electron beam. If water is present in 
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the sample, it will vaporize and disrupt the equipment. Non-metal samples must be sputter 
coated with a conductive material. [8] 
The peptoid samples were dried on silicon chips at room temperature for 30 minutes 
then sputter coated with gold before being imaged. These images were used to determine if 
spheres formed on the surface of a dry substrate. 
Section 3.6: Dynamic Light Scattering 
 Dynamic light scattering (DLS) predicts the size of spherical particles in solution. The 
instrument sends a laser beam through the sample as shown in Figure 6. It then measures the 
transmitted light shown as “PD” in the figure and scattered light at either 90° or 173° depending 
on the concentration of the particles. This data is used to determine the size of the particles in 
solution. [11] 
 
Figure 6: Dynamic Light Scattering Set-up [11] 
The particles are assumed to be in Brownian motion therefore the probability density 
function is known. Using the transmitted and scattered light data, the diffusion constant can be 
calculated with the probability density function. Stokes-Einstein relation can then be applied 
based on the assumption that the particles are small. This yields an equation for the diffusion 
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constant that is based on the particle radius, the Boltzmann constant, temperature, and the 
viscosity of the solvent. [12] 
To conduct this experiment, each peptoid was dissolved in a 4 to 1 ethanol and water 
solution at 3 mg/mL. The program used the light intensity data to calculate volume and the 
number of particles for each diameter. 
Section 3.7: Transmission Electron Microscopy 
 To perform transmission electron microscopy (TEM), 1 µL of 3 mg/ mL peptoid dissolved 
in a 4 to 1 methanol and water solution was mixed with 1 µL 1% uranyl acetate and dried on 
copper mesh at room temperature for 24 hours. Once dried, the samples were viewed using 
TEM, which is similar to SEM except the transmitted light is detected instead of the scattered 
light. [13] 
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Chapter 4: Results 
 The peptoids were synthesized then purified using HPLC. MALDI was used to determine 
if the peptoids were properly synthesized. Analytical HPLC was performed to ensure the 
peptoids were above 98% pure. The peptoids tested during this study are shown in Table 1 
below. 
Table 1: Peptoid Sequences 
Peptoid Sequence Molecular Weight 
P1 
 
1866 
wP1 
 
1824 
rP1 
 
1866 
P3 
 
1919 
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Section 4.1: Circular Dichroism 
 Based on previous research conducted in the Servoss lab, in order for nanosphere 
formation to occur, peptoids need to form a polyproline type 1-like helix. All four peptoids were 
determined to have this secondary structure based on their minima around 200 and 220 nm. [5] 
Figure 7 shows typical circular dichroism results from literature and Figure 8 shows the results 
obtained by another student in Servoss’s lab for the peptoids used in this study. 
  
Figure 7: Circular Dichroism Literature Values [14] 
 
 
Figure 8: Circular Dichroism Results [5] 
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Section 4.2: Scanning Electron Microscopy 
 Scanning electron microscopy was used to determine if peptoid nanospheres formed on 
a solid substrate. This experiment was performed previously then redone before testing the 
peptoids further. The figure below shows representative SEM images for the four peptoids 
tested. P3 was the only peptoid that showed uniform sphere formation when dried on a solid 
substrate. 
 
Figure 9: SEM Images A) P1 (scale bar = 5 µm) B) wP1 (scale bar = 10 µm) C) rP1 (scale bar = 5 
µm) D) P3 (scale bar = 10 µm) 
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Section 4.3: Dynamic Light Scattering 
 Dynamic light scattering was used to determine the size of particles in solution. The 
graphs with multiple peaks were determined to not form uniform spheres in solution because 
either they formed spheres of multiple sizes or the particles were different sizes in different 
directions. The peptoids with a single DLS peak were tested using transmission electron 
microscopy. 
 
Figure 10: DLS Data 
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Section 4.4: Transmission Electron Microscopy 
 Transmission electron microscopy was performed on two of the peptoids. One of the 
peptoids, P3, formed spheres which were analyzed using Image J. The data from Image J was 
averaged in excel. P3 was found to have an average diameter of around 500 nm. 
 
Figure 11: TEM Images 
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Chapter 5: Discussion 
 The scanning electron microscopy showed if spheres formed when dried on a solid 
substrate. To determine if the spheres formed in solution or during the drying process, dynamic 
light scattering and transmission electron microscopy tests were performed. The TEM images 
were analyzed and the average diameter was determined. This was compared to the diameters 
predicted by DLS. These were approximately 500 nm and 600 nm respectively. Because the 
diameters were less than 20 % different, it can be assumed that the spheres formed in solution. 
The error could be due to the inaccuracy of using ImageJ to estimate the size of the spheres, but 
it is more likely due to error in the DLS calculations. DLS accounts for solvent properties when 
making size predictions. For these tests a pure solvent was not used; however, DLS was set to 
use the properties of pure methanol for its predictions. This mixture would change the viscosity 
of the solvent which would change the size predictions. 
Chapter 6: Conclusion 
 While all four peptoids appear to be forming secondary structures, only one of the 
peptoids formed nanospheres in solution. This indicates that although helicity may be required 
for nanospheres formation, it is not the only factor. Peptoids are protease resistant and can be 
manipulated to carry drugs to the disease site. Based on these results peptoids show promise as 
a drug delivery system.  
Chapter 7: Recommendations 
 To build on this study the peptoids should also be tested in other solvents. Specifically, 
the peptoids should be tested in a biocompatible solvent and in the presence of salts. 
Determining if the spheres are stable in the body is key for them to be used for drug delivery. 
Using the knowledge gained from these experiments, new peptoids can be designed that are 
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more biocompatible and more stable in the body. The spheres should then be attached to a 
peptoid that is known to target VGFR. DLS and TEM should be repeated to determine if VGFR 
interferes with sphere formation. 
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